D Hema

Assistant Professor, RVM Institute of Medical Sciences and Research Centre, Laxmakkapally(V), Mulugu(M), Siddipet(D), Telangana.

Email: rvmims@gmail.com

REFERENCES

1. Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health Qual Life Outcomes 2006;4:35.
2. WHO Library Cataloguing-in-Publication Data, Global report on psoriasis 2016
3. Reich K. The concept of psoriasis as a systemic inflammation: implications for disease management. J Eur Acad Dermatol Venereol 2012; 26: 3–11.
4. Ernste FC, S_anchez-Men_endez M, Wilton KM, Crowson CS, Matteson EL, Maradit Kremers H. Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study. Arthritis Care Res 2015; 67: 1015–1021.
5. Edson-Heredia E, Zhu B, Lefevre C et al. Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink. J Eur Acad Dermatol Venereol 2015; 29: 955–963.
6. Paolo Gisondi, Anna Ferrazzi, Giampiero Girolomoni. Metabolic Comorbidities and Psoriasis. Acta Dermatovenerol Croat., 2010; 18(4): 297-304.
7. Gisondi P, Girolomoni G, Sampogna F, Tabolli S, Abeni D. Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. Eur J Dermatol., 2005; 15: 279-83.
8. Sarkar S, Sarkar A, Saha R, Sarkar T. Psoriasis and psychiatric morbidity: a profile from a tertiary care centre of eastern India. J Fam Med Prim Care 2014;3:29-32.
9. Nevitt, G. J. and P. E. Hutchinson (1996). "Psoriasis in the community: prevalence, severity, and patients' beliefs and attitudes towards the disease." Br J Dermatol 135(4): 533-7.
10. Smith AE, Kassab JY, Rowland Payne CM, Beer WE. Bimodality in age of onset of psoriasis, in both patients and their relatives. Dermatology 1993;186:181-6
11. Pavithran K. Disorders of keratinization. In: Valia RG, Ameet RV, editors. IADVL Textbook and atlas of Dermatology. 2nd ed., Vol. II. Mumbai: Bhalani Publishing House; 2001. p. 799-846.
12. Menter A, Griffiths CEM, Tebbey PW, Horn EJ, Sterry W. Exploring the association between cardiovascular and other disease‑related risk factors in the psoriasis population: The need for increased understanding across the medical community. J Eur Aacd Dermatol Venereol 2010:24:1371‑7.
13. Prey S, Paul C, Bronsard P, Puzenat E, Gourraud PA, Aractingi S, et al. Cardiovascular risk factors in patients with plaque psoriasis: A systematic review of epidemiological studies. J Eur Aacd Dermatol Venereol 2010,24:S: 23‑30.
14. Miller IM, Ellervik C, Yazdanyar S, Jemec GB. Meta‑analysis of psoriasis, cardiovascular disease, and associated risk factors. J Am Acad Dermatol 2013;69:1014‑24.
15. Karoli R, Fatima J, Shukla V, Dhillon KS, Khanduri S, Maini S, et al. A study of cardio‑metabolic risk profile in patients with psoriasis. J Assoc Physicians India 2013;61:798‑803.
16. Ali NM, Kuruvila M, Unnikrishnan B. Psoriasis and metabolic syndrome: A case control study. Indian J Dermatol Venereol Leprol 2014;80:255‑7.
17. Kothiwala SK, Khanna N, Tandon N, Naik N, Sharma VK, Sharma S, et al. Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: A hospital‑based cross‑sectional study. Indian J Dermatol Venereol Leprol 2016;82:510‑8.
18. Praveenkumar U, Ganguly S, Ray L, Nanda SK, Kuruvila S. Prevalence of Metabolic Syndrome in Psoriasis Patients and its Relation to Disease Duration: A Hospital Based Case‑Control Study. J Clin Diagn Res 2016;10:WC01‑5.